Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Germline and somatic mutations in prostate cancer: focus on defective DNA repair, PARP inhibitors and immunotherapy.

Cimadamore A, Lopez-Beltran A, Massari F, Santoni M, Mazzucchelli R, Scarpelli M, Galosi AB, Cheng L, Montironi R.

Future Oncol. 2020 Jan 9. doi: 10.2217/fon-2019-0745. [Epub ahead of print] No abstract available.

PMID:
31916449
2.

Risk of Acute Myocardial Infarction Among New Users of Allopurinol According to Serum Urate Level: A Nested Case-Control Study.

Rodríguez-Martín S, de Abajo FJ, Gil M, González-Bermejo D, Rodríguez-Miguel A, Barreira-Hernández D, Mazzucchelli R, García-Lledó A, García-Rodríguez LA.

J Clin Med. 2019 Dec 5;8(12). pii: E2150. doi: 10.3390/jcm8122150.

3.

East-west gradient in hip fracture incidence in Spain: how much can we explain by following the pattern of risk factors?

Mazzucchelli R, Pérez Fernández E, Crespí Villarías N, Tejedor Alonso MÁ, Sáez López P, García-Vadillo A.

Arch Osteoporos. 2019 Nov 27;14(1):115. doi: 10.1007/s11657-019-0665-3.

PMID:
31773387
4.

Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma.

Santoni M, Heng DY, Aurilio G, Iozzelli A, Servi L, Fabiani A, Giannini M, Mazzucchelli R, Cimadamore A, Scarpelli M, Zaghloul MS, Battelli N, Montironi R.

Curr Drug Targets. 2019 Oct 17. doi: 10.2174/1389450120666191017113051. [Epub ahead of print]

PMID:
31625471
5.

Mortality after osteoporotic hip fracture: incidence, trends, and associated factors.

Guzon-Illescas O, Perez Fernandez E, Crespí Villarias N, Quirós Donate FJ, Peña M, Alonso-Blas C, García-Vadillo A, Mazzucchelli R.

J Orthop Surg Res. 2019 Jul 4;14(1):203. doi: 10.1186/s13018-019-1226-6.

6.

Orthopedic Surgery in Rheumatoid Arthritis: Results from the Spanish National Registry of Hospitalized Patients over 17 Years.

Peña M, Quirós-Donate J, Pérez Fernández E, Crespí-Villarías N, Dieguez Costa E, García-Vadillo A, Espinosa M, Macía-Villa C, Morell-Hita JL, Martinez-Prada C, Villaverde V, Morado Quiroga I, Guzón-Illescas O, Barbadillo C, Fernandez Prada M, Godoy H, Herranz Varela A, Galindo Izquierdo M, Mazzucchelli R.

J Rheumatol. 2019 Jun 15. pii: jrheum.190182. doi: 10.3899/jrheum.190182. [Epub ahead of print]

PMID:
31203231
7.

Evidence-based algorithm to treat patients with proximal humerus fractures-a prospective study with early clinical and overall performance results.

Spross C, Meester J, Mazzucchelli RA, Puskás GJ, Zdravkovic V, Jost B.

J Shoulder Elbow Surg. 2019 Jun;28(6):1022-1032. doi: 10.1016/j.jse.2019.02.015. Epub 2019 Apr 16.

PMID:
31003888
8.

Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project.

Santagostino E, Riva A, Cesaro S, Esposito S, Matino D, Mazzucchelli RI, Molinari AC, Mura R, Notarangelo LD, Tagliaferri A, Di Minno G, Clerici M; the HEVA Study Group.

Haemophilia. 2019 Jul;25(4):656-667. doi: 10.1111/hae.13756. Epub 2019 Apr 16.

9.

Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma.

Santoni M, Piva F, De Giorgi U, Mosca A, Basso U, Santini D, Buti S, Lolli C, Terrone C, Maruzzo M, Iuliani M, Bersanelli M, Conti A, Mazzucchelli R, Montironi R, Burattini L, Berardi R.

Anticancer Res. 2018 Oct;38(10):5773-5782. doi: 10.21873/anticanres.12916.

PMID:
30275199
10.

Short-term association between outdoor air pollution and osteoporotic hip fracture.

Mazzucchelli R, Crespi Villarias N, Perez Fernandez E, Durban Reguera ML, Garcia-Vadillo A, Quiros FJ, Guzon O, Rodriguez Caravaca G, Gil de Miguel A.

Osteoporos Int. 2018 Oct;29(10):2231-2241. doi: 10.1007/s00198-018-4605-7. Epub 2018 Aug 9.

PMID:
30094608
11.

Trends in hip fracture in patients with rheumatoid arthritis: results from the Spanish National Inpatient Registry over a 17-year period (1999-2015). TREND-AR study.

Mazzucchelli R, Pérez Fernandez E, Crespí-Villarías N, Quirós-Donate J, García Vadillo A, Espinosa M, Peña M, Macía-Villa C, Morell-Hita JL, Martinez-Prada C, Villaverde V, Morado Quiroga I, Guzón-Illescas O, Barbadillo C, Fernández Prada M, Godoy H, Herranz Varela A, Galindo Izquierdo M, Rodriguez Caravaca G.

RMD Open. 2018 Jun 4;4(1):e000671. doi: 10.1136/rmdopen-2018-000671. eCollection 2018.

12.

High Reproducibility of an Automated Measurement of Mobility for Patients with Axial Spondyloarthritis.

Garrido-Castro JL, Curbelo R, Mazzucchelli R, Domínguez-González ME, Gonzalez-Navas C, Flores Robles BJ, Zarco P, Mulero J, Cea-Calvo L, Arteaga MJ, Font-Ugalde P, Carmona L, Collantes-Estevez E.

J Rheumatol. 2018 Oct;45(10):1383-1388. doi: 10.3899/jrheum.170941. Epub 2018 Jun 15.

PMID:
29907675
13.

Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma.

Montironi R, Cimadamore A, Gasparrini S, Mazzucchelli R, Santoni M, Massari F, Cheng L, Lopez-Beltran A, Scarpelli M.

Expert Rev Anticancer Ther. 2018 Jul;18(7):685-693. doi: 10.1080/14737140.2018.1469406. Epub 2018 Apr 27. Review.

PMID:
29699428
14.

Weather conditions and their effect on seasonality of incident osteoporotic hip fracture.

Mazzucchelli R, Crespí-Villarías N, Pérez-Fernández E, Durbán Reguera ML, Guzón Illescas O, Quirós J, García-Vadillo A, Carmona L, Rodriguez-Caravaca G, Gil de Miguel A.

Arch Osteoporos. 2018 Mar 15;13(1):28. doi: 10.1007/s11657-018-0438-4.

PMID:
29546463
15.

Long Non-coding RNAs in Prostate Cancer with Emphasis on Second Chromosome Locus Associated with Prostate-1 Expression.

Cimadamore A, Gasparrini S, Mazzucchelli R, Doria A, Cheng L, Lopez-Beltran A, Santoni M, Scarpelli M, Montironi R.

Front Oncol. 2017 Dec 12;7:305. doi: 10.3389/fonc.2017.00305. eCollection 2017. Review.

16.

The influence of local bone quality on fracture pattern in proximal humerus fractures.

Mazzucchelli RA, Jenny K, Zdravkovic V, Erhardt JB, Jost B, Spross C.

Injury. 2018 Feb;49(2):359-363. doi: 10.1016/j.injury.2017.12.020. Epub 2017 Dec 26.

PMID:
29287662
17.

Second Hip Fracture: Incidence, Trends, and Predictors.

Mazzucchelli R, Pérez-Fernández E, Crespí N, García-Vadillo A, Rodriguez Caravaca G, Gil de Miguel A, Carmona L.

Calcif Tissue Int. 2018 Jun;102(6):619-626. doi: 10.1007/s00223-017-0364-2. Epub 2017 Nov 20.

PMID:
29159516
18.

The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer.

Avellini C, Licini C, Lazzarini R, Gesuita R, Guerra E, Tossetta G, Castellucci C, Giannubilo SR, Procopio A, Alberti S, Mazzucchelli R, Olivieri F, Marzioni D.

Oncotarget. 2017 Apr 25;8(35):58642-58653. doi: 10.18632/oncotarget.17407. eCollection 2017 Aug 29.

19.

A composite indicator to assess the quality of care in the management of patients with rheumatoid arthritis in outpatient rheumatology clinics.

Martín-Martínez MA, Andreu-Sanchez JL, Sanchez-Alonso F, Corominas H, Perez-Venegas JJ, Roman-Ivorra JA, Alperi M, Blanco-Alonso R, Caliz R, Chamizo-Carmona E, Graña-Gil J, Hernández B, Marras C, Mazzucchelli R, Medina Luezas JA, Naranjo-Hernández A, Ortiz A, Roselló R, Sanchez-Nievas G, Sanmartí R, Vela-Casasempere P; en representación del Comité Científico del trabajo Indicador Compuesto para evaluar la calidad asistencial en el manejo de los pacientes con artritis reumatoide en las consultas externas de Reumatología.

Reumatol Clin. 2019 May - Jun;15(3):156-164. doi: 10.1016/j.reuma.2017.06.017. Epub 2017 Aug 6. English, Spanish.

20.

Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians.

Gasparrini S, Cimadamore A, Scarpelli M, Massari F, Doria A, Mazzucchelli R, Cheng L, Lopez-Beltran A, Montironi R.

Asian J Androl. 2017 Aug 4. doi: 10.4103/aja.aja_24_17. [Epub ahead of print]

21.

Pathology and molecular updates in tumors of the prostate: towards a personalized approach.

Gasparrini S, Cimadamore A, Mazzucchelli R, Scarpelli M, Massari F, Raspollini MR, Galosi AB, Lopez-Beltran A, Cheng L, Montironi R.

Expert Rev Mol Diagn. 2017 Aug;17(8):781-789. doi: 10.1080/14737159.2017.1341314. Epub 2017 Jun 15. Review.

PMID:
28598696
22.

Low HtrA1 expression in patients with long‑standing ulcerative colitis and colorectal cancer.

Altobelli E, Latella G, Morroni M, Licini C, Tossetta G, Mazzucchelli R, Profeta VF, Coletti G, Leocata P, Castellucci M, Guerrieri M, Petrocelli R, De Berardis B, De Padova M, Di Leonardo G, Paladini A, Mignosi F, Quaglione G, Fagnano R, Marzioni D.

Oncol Rep. 2017 Jul;38(1):418-426. doi: 10.3892/or.2017.5700. Epub 2017 Jun 6.

PMID:
28586045
23.

A painful diagnosis.

Fraticelli P, Cardinali M, Biondi L, Benfaremo D, Mattioli M, Mazzucchelli R, Montironi R, Gabrielli A.

Intern Emerg Med. 2017 Apr;12(3):341-347. doi: 10.1007/s11739-017-1638-4. Epub 2017 Feb 25. No abstract available.

PMID:
28238180
24.

Epigenetic Modifications and Modulators in Prostate Cancer.

Cimadamore A, Gasparrini S, Scarpelli M, Doria A, Mazzucchelli R, Massari F, Cheng L, Lopez-Beltran A, Montironi R.

Crit Rev Oncog. 2017;22(5-6):439-450. doi: 10.1615/CritRevOncog.2017020964. Review.

PMID:
29604923
25.

Prostate cancer grading in 2016.

Gasparrini S, Mazzucchelli R, Scarpelli M, Massari F, Raspollini MR, Lopez-Beltran A, Cheng L, Montironi R.

Minerva Urol Nefrol. 2017 Feb;69(1):1-4. Epub 2016 Nov 4. No abstract available.

26.

Re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738-9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides.

Montironi R, Gasparrini S, Mazzucchelli R, Massari F, Cheng L, Lopez-Beltran A, Montorsi F, Scarpelli M.

Eur Urol. 2017 Feb;71(2):e73-e75. doi: 10.1016/j.eururo.2016.08.036. Epub 2016 Aug 25. No abstract available.

PMID:
27568062
27.

Genitourinary cancers: molecular determinants for personalized therapies.

Mazzucchelli R, Gasparrini S, Galosi AB, Massari F, Raspollini MR, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R.

Urologia. 2016 Sep 26;83(3):107-109. doi: 10.5301/uro.5000187. Epub 2016 Jun 23.

PMID:
27338983
28.

Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3.

Minardi D, Mazzucchelli R, Scarpelli M, Massari F, Ciccarese C, Lopez-Beltran A, Cheng L, Montironi R.

Future Oncol. 2016 Jun;12(12):1431-3. doi: 10.2217/fon-2016-0113. Epub 2016 Mar 30. No abstract available.

29.

Immunotargeting and personalized therapies in genitourinary cancers.

Mazzucchelli R, Gasparrini S, Galosi AB, Massari F, Ciccarese C, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R.

Future Oncol. 2016 Aug;12(16):1853-6. doi: 10.2217/fon-2016-0183. Epub 2016 Apr 26. No abstract available.

PMID:
27113700
30.

Prostate cancer: from Gleason scoring to prognostic grade grouping.

Montironi R, Santoni M, Mazzucchelli R, Burattini L, Berardi R, Galosi AB, Cheng L, Lopez-Beltran A, Briganti A, Montorsi F, Scarpelli M.

Expert Rev Anticancer Ther. 2016;16(4):433-40. doi: 10.1586/14737140.2016.1160780. Review.

PMID:
27008205
31.

Metabolic phenotype of bladder cancer.

Massari F, Ciccarese C, Santoni M, Iacovelli R, Mazzucchelli R, Piva F, Scarpelli M, Berardi R, Tortora G, Lopez-Beltran A, Cheng L, Montironi R.

Cancer Treat Rev. 2016 Apr;45:46-57. doi: 10.1016/j.ctrv.2016.03.005. Epub 2016 Mar 8. Review.

PMID:
26975021
32.

Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients.

Conti A, Santoni M, Burattini L, Scarpelli M, Mazzucchelli R, Galosi AB, Cheng L, Lopez-Beltran A, Briganti A, Montorsi F, Montironi R.

World J Urol. 2017 Apr;35(4):517-526. doi: 10.1007/s00345-015-1752-8. Epub 2015 Dec 22. Review.

PMID:
26694187
33.

[Diagnosis of Alport syndrome].

Frascà GM, Taruscia D, Nastasi V, Balestra E, Pugliese S, Mazzucchelli R.

G Ital Nefrol. 2015;32 Suppl 64. pii: gin/32.S64.5. Italian.

PMID:
26479052
34.

Metabolic Alterations in Renal and Prostate Cancer.

Ciccarese C, Santoni M, Massari F, Modena A, Piva F, Conti A, Mazzucchelli R, Cheng L, Lopez-Beltran A, Scarpelli M, Tortora G, Montironi R.

Curr Drug Metab. 2016;17(2):150-5. Review.

PMID:
26467063
35.

Role of the pathologist in active surveillance for prostate cancer.

Mazzucchelli R, Galosi AB, Santoni M, Lopez-Beltran A, Scarpelli M, Cheng L, Montironi R.

Anal Quant Cytopathol Histpathol. 2015 Feb;37(1):65-8. Review.

PMID:
26072636
36.

Current Histopathologic and Molecular Characterisations of Prostate Cancer: Towards Individualised Prognosis and Therapies.

Santoni M, Scarpelli M, Mazzucchelli R, Lopez-Beltran A, Cheng L, Epstein JI, Cascinu S, Briganti A, Catto JW, Montorsi F, Montironi R.

Eur Urol. 2016 Feb;69(2):186-90. doi: 10.1016/j.eururo.2015.05.041. Epub 2015 Jun 10.

37.

Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report.

Montironi R, Santoni M, Goteri G, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M.

Hum Pathol. 2015 Jul;46(7):1040-4. doi: 10.1016/j.humpath.2015.03.004. Epub 2015 Mar 25.

PMID:
25912755
38.

Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance.

Mazzucchelli R, Galosi AB, Lopez-Beltran A, Scarpelli M, Cheng L, Montironi R.

Arch Ital Urol Androl. 2014 Dec 30;86(4):314-8. doi: 10.4081/aiua.2014.4.314. Review.

39.

Targeting prostate-specific membrane antigen for personalized therapies in prostate cancer: morphologic and molecular backgrounds and future promises.

Santoni M, Scarpelli M, Mazzucchelli R, Lopez-Beltran A, Cheng L, Cascinu S, Montironi R.

J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):555-63. Review.

PMID:
25620167
40.

Pathology of upper tract urothelial carcinoma with emphasis on staging.

Mazzucchelli R, Scarpelli M, Galosi AB, Di Primio R, Lopez-Beltran A, Cheng L, Montironi R.

Int J Immunopathol Pharmacol. 2014 Oct-Dec;27(4):509-16. Review.

PMID:
25572730
41.

Survival in patients with clear cell renal cell carcinoma is predicted by HIF-1α expression.

Minardi D, Lucarini G, Santoni M, Mazzucchelli R, Burattini L, Conti A, Principi E, Bianconi M, Scartozzi M, Milanese G, Di Primio R, Montironi R, Cascinu S, Muzzonigro G.

Anticancer Res. 2015 Jan;35(1):433-8.

PMID:
25550584
42.

Inflammatory back pain in a 44 year old male.

Escudero R, Almodóvar R, Zarco P, Bueno Á, Dhimes P, Mazzucchelli R, Quirós FJ.

Reumatol Clin. 2015 Sep-Oct;11(5):325-7. doi: 10.1016/j.reuma.2014.11.004. Epub 2014 Dec 15. English, Spanish. No abstract available.

43.

Renal cell carcinoma with rhabdoid features and loss of INI1 expression in an individual without sickle cell trait.

Scarpelli M, Mazzucchelli R, Lopez-Beltran A, Cheng L, De Nictolis M, Santoni M, Montironi R.

Pathology. 2014 Dec;46(7):653-5. doi: 10.1097/PAT.0000000000000175. No abstract available.

PMID:
25393261
44.

Does prostate acinar adenocarcinoma with Gleason Score 3+3=6 have the potential to metastasize?

Montironi R, Scarpelli M, Mazzucchelli R, Lopez-Beltran A, Santoni M, Briganti A, Montorsi F, Cheng L.

Diagn Pathol. 2014 Oct 18;9:190. doi: 10.1186/s13000-014-0190-z.

45.

Prostate changes related to therapy: with special reference to hormone therapy.

Mazzucchelli R, Lopez-Beltran A, Galosi AB, Zizzi A, Scarpelli M, Bracarda S, Cheng L, Montironi R.

Future Oncol. 2014 Aug;10(11):1873-86. doi: 10.2217/fon.14.37. Review.

PMID:
25325826
46.

Total submission of lymphadenectomy tissues removed during radical prostatectomy for prostate cancer: possible clinical significance of large-format histology.

Montironi R, Scarpelli M, Galosi AB, Lopez-Beltran A, Mazzucchelli R, Montorsi F, Cheng L.

Hum Pathol. 2014 Oct;45(10):2059-62. doi: 10.1016/j.humpath.2014.06.023. Epub 2014 Jul 17.

PMID:
25149553
47.

Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma.

Minardi D, Santoni M, Lucarini G, Mazzucchelli R, Burattini L, Conti A, Bianconi M, Scartozzi M, Milanese G, Primio RD, Montironi R, Cascinu S, Muzzonigro G.

Urol Oncol. 2015 Mar;33(3):113.e1-7. doi: 10.1016/j.urolonc.2014.06.014. Epub 2014 Jul 26.

PMID:
25069421
48.

Contemporary update on pathology-related issues of adult renal neoplasms.

Mazzucchelli R, Galosi AB, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R.

Anal Quant Cytopathol Histpathol. 2014 Feb;36(1):1-8. Review.

PMID:
24902365
49.

Contemporary update on pathology-related issues on routine workup of prostate biopsy: sectioning, tumor extent measurement, specimen orientation, and immunohistochemistry.

Montironi R, Lopez-Beltran A, Mazzucchelli R, Scarpelli M, Galosi AB, Cheng L.

Anal Quant Cytopathol Histpathol. 2014 Apr;36(2):61-70. Review.

PMID:
24902358
50.

Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma.

Galosi AB, Scarpelli M, Mazzucchelli R, Lopez-Beltran A, Giustini L, Cheng L, Montironi R.

Diagn Pathol. 2014 May 6;9:90. doi: 10.1186/1746-1596-9-90.

Supplemental Content

Loading ...
Support Center